Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF)
In conclusion, ALYREF may serve as an oncogenic biomarker in numerous cancers, meriting further research attention.PMID:38361753 | PMC:PMC10865740 | DOI:10.32604/or.2024.045050
Source: Oncology Research - Category: Cancer & Oncology Authors: Xing Ye Zhouting Tuo Kai Chen Ruicheng Wu Jie Wang Qingxin Yu Luxia Ye Akira Miyamoto Koo Han Yoo Chi Zhang Wuran Wei Dengxiong Li Dechao Feng Source Type: research
More News: Asbestosis | Brain Tumor | Cancer | Cancer & Oncology | Carcinoma | Genetics | Glioma | Hepatocellular Carcinoma | Liver | Liver Cancer | Lymphoma | Mesothelioma | Paraganglioma | Pheochromocytoma | Skin Cancer | Squamous Cell Carcinoma | Study | Urology & Nephrology